Enrolling Now

Enrolling Now

See if you qualify

Daily Oral Medication

Obesity or Overweight, with or without Type 2 Diabetes

Locations: Manhattan and Long Island City

Cost to you: none for study visits, tests, or study medication

Questions: 516-574-9232 · Hablamos español

  • Study to Investigate the Efficacy and Safety of a Once Daily Oral Medication in Adult Participants with Obesity or Overweight, with or without Type 2 Diabetes.

    • ≥18 years of age

    • Stable weight and at least one prior unsuccessful attempt at weight loss through diet

    • BMI ≥30 kg/m2; OR BMI 25 to 29.9 kg/m2 with hypertension, prediabetes, dyslipidemia, cardiovascular disease, or obstructive sleep apnea

    • Participants with or without Type 2 Diabetes may qualify (separate study pathways)

    • If Type 2 Diabetes: BMI ≥25 kg/m2 and HbA1c generally below 10%

    • No GLP-1 or weight loss medication within the past 90 days

    • No prior or planned bariatric procedure

    • No history of pancreatitis

    • No uncontrolled thyroid disease

    • No recent major cardiovascular event

    • No significant liver disease

  • Gain access to cutting-edge medications and treatments before they are widely available.

    Our expert team is under the guidance of renowned endocrinologist, Dr. Anastasios Manessis.

    We are highly focused on patient well-being and the highest ethical standards in clinical research.

A yellow background with a coiled white measuring tape, some white pills scattered near the tape.

Pre-screen for this study

Answer a few questions and a study coordinator will call you to go over the next steps. Your information is used only to contact you about this study.